Alkermes to Report First Quarter Financial Results on April 26, 2023

Rhea-AI Summary

On April 19, 2023, Alkermes plc (NASDAQ: ALKS) announced a conference call and webcast scheduled for April 26, 2023, at 8:00 a.m. ET to discuss its first quarter financial results. Interested parties can access the event through Alkermes' website, with a replay available two hours post-event. Alkermes focuses on developing innovative medications in neuroscience and oncology, with products targeting alcohol and opioid dependence, schizophrenia, and bipolar I disorder. The company has a global presence with facilities in Ireland and the U.S. Investors can expect insights into the company's financial performance and future outlook during the call.

Positive

• Scheduled conference call for April 26, 2023, to discuss first quarter results.
• Focus on innovative medicines in neuroscience and oncology.

Negative

• None.

DUBLIN, April 19, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. BST) on Wednesday, April 26, 2023 to discuss the company's first quarter financial results.

The webcast player and accompanying slides may be accessed on the Investors section of Alkermes' website at www.alkermes.com. The conference call may be accessed by dialing +1 877 407 2988 for U.S. callers and +1 201 389 0923 for international callers. A replay of the webcast will be available approximately two hours after the completion of the event and may be accessed by visiting Alkermes' website. 

About Alkermes plc
Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Headquartered in Dublin, Ireland, Alkermes has a research and development center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Alkermes Contact:
Jamie Bernard 
Investor Relations 
+1 781 873 2402

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/alkermes-to-report-first-quarter-financial-results-on-april-26-2023-301802092.html

SOURCE Alkermes plc

FAQ

When will Alkermes report its first quarter financial results?

Alkermes will report its first quarter financial results on April 26, 2023.

How can I access the Alkermes first quarter financial results conference call?

The conference call can be accessed by dialing +1 877 407 2988 for U.S. callers and +1 201 389 0923 for international callers.

What topics will be discussed during the Alkermes conference call?

The conference call will discuss Alkermes' first quarter financial results and company developments.

Where can I find the replay of the Alkermes conference call?

A replay of the conference call will be available on Alkermes' website approximately two hours after the event.